PlainRecalls

Forest Pharmaceuticals Inc

Compiled from official public sources by the publisher.

6 recalls on record · Latest: Oct 29, 2014

Subscribe to new Forest Pharmaceuticals Inc recalls (RSS)

Agency notice ledger

Federal filing book Forest Pharmaceuticals Inc LIGHT-BOOK · SINGLE-AGENCY

#2,155 of 14,151 · 6 notices · 0.006% archive

  • BOOK 6 notices
  • RANK #2,155 of 14,151
  • SHARE 0.006% archive
  • AGENCY FDA Drug (6)
  • CAT drugs
  • CATS 2 categories
  • LATEST Oct 29, 2014
  • PHOTO 1908 Brands

Nearest notice-volume peer: 1908 Brands (0 notice gap)

Forest Pharmaceuticals Inc accounts for about 0.006% of the 104,423-notice archive on 6 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Forest Pharmaceuticals Inc's standing among 14,151 recalling firms

Forest Pharmaceuticals Inc ranks 2,155th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Forest Pharmaceuticals Inc vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

6 2155th of 14151 higher than 11,804 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Forest Pharmaceuticals Inc in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Forest Pharmaceuticals Inc holds about 0.006% of archive notices alongside 6 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Oct 29, 2014

Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. --- NDC 0456-1420-07
FDA Drug Moderate Jul 9, 2014

Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.
FDA Drug Moderate May 28, 2014

Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license from Janssen Pharmaceutica NV, Belgium, Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, NDC 0456-1420-30
FDA Drug Low Feb 12, 2014

Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC 0456-3407-33
FDA Drug Low Feb 12, 2014

Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3428-05.
FDA Drug Low Feb 12, 2014

Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titration pack,Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3400-29.

Forest Pharmaceuticals Inc holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (6 here).

1908 Brands 6 Abbott Molecular 6 Accriva Diagnostics, Inc. 6 Advance Medical Designs, Inc. 6 Agave Dream 6

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Appco Pharma LLC 6 Aspen Biopharma Labs Pvt., Ltd. 6 Bausch Health Companies, Inc. 6 Bayer Healthcare, LLC 6

Frequently Asked Questions

How many federal recall notices name Forest Pharmaceuticals Inc? ▼
PlainRecalls indexes 6 distinct federal recall events naming Forest Pharmaceuticals Inc, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Forest Pharmaceuticals Inc sit among other recalling firms? ▼
Forest Pharmaceuticals Inc ranks #2,155 of 14,151 by distinct recall-event count among 14,151 firms in this archive (83rd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Forest Pharmaceuticals Inc's notices? ▼
FDA Drug accounts for 6 of this firm's 6 indexed notices.
What product category dominates Forest Pharmaceuticals Inc's filing book? ▼
Filings for Forest Pharmaceuticals Inc span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Forest Pharmaceuticals Inc: 6 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Forest Pharmaceuticals Inc; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026